Validated germline-competent embryonic stem cell lines from nonobese diabetic mice

Jennifer Nichols1, Kenneth Jones, Jenny M Phillips

  • 1Wellcome Trust Centre for Stem Cell Research, University of Cambridge, Cambridge, UK.

Nature Medicine
|June 4, 2009
PubMed
Summary

Researchers have derived new embryonic stem (ES) cell lines from Nonobese diabetic (NOD) mice. These cells enable genetic modification and germline transmission, aiding type 1 diabetes research.

Related Concept Videos